Efficacy of the human papillomavirus HPV16/18 AS04 Adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV16/18

A Szarewski; WA Poppe; SR Skinner; Henry Kitchener; The PATRICIA Study Group

Efficacy of the human papillomavirus HPV16/18 AS04 Adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV16/18

A Szarewski, WA Poppe, SR Skinner, Henry Kitchener, The PATRICIA Study Group

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	International Journal of Cancer
Publication status	Published - 19 Aug 2011

Cite this

@article{361873b54ffc49ffb3176d1a9fb59612,

title = "Efficacy of the human papillomavirus HPV16/18 AS04 Adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV16/18",

author = "A Szarewski and WA Poppe and SR Skinner and Henry Kitchener and {The PATRICIA Study Group}",

year = "2011",

month = aug,

day = "19",

language = "English",

journal = "International Journal of Cancer",

issn = "1097-0215",

publisher = "John Wiley & Sons Ltd",

}

TY - JOUR

T1 - Efficacy of the human papillomavirus HPV16/18 AS04 Adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV16/18

AU - Szarewski, A

AU - Poppe, WA

AU - Skinner, SR

AU - Kitchener, Henry

AU - The PATRICIA Study Group

PY - 2011/8/19

Y1 - 2011/8/19

M3 - Article

SN - 1097-0215

JO - International Journal of Cancer

JF - International Journal of Cancer

ER -